![](/img/cover-not-exists.png)
A Phase I/II Trial of the Interleukin-6 Receptor–Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize Patients
Vo, Ashley A., Choi, Jua, Kim, Irene, Louie, Sabrina, Cisneros, Kristen, Kahwaji, Joseph, Toyoda, Mieko, Ge, Shili, Haas, Mark, Puliyanda, Dechu, Reinsmoen, Nancy, Peng, Alice, Villicana, Rafael, JordVolume:
99
Language:
english
Journal:
Transplantation
DOI:
10.1097/tp.0000000000000741
Date:
November, 2015
File:
PDF, 546 KB
english, 2015